Literature DB >> 9213376

Is methotrexate oncogenic in patients with rheumatoid arthritis?

J M Kremer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9213376     DOI： 10.1016/s0049-0172(97)80021-2

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN： 0049-0172            Impact factor:   5.532


× No keyword cloud information.
  3 in total

1.  Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas.

Authors:  P Geborek; A Bladström; C Turesson; A Gulfe; I F Petersson; T Saxne; H Olsson; L T H Jacobsson
Journal:  Ann Rheum Dis       Date:  2005-02-04       Impact factor: 19.103

2.  A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort.

Authors:  Rachael L Gross; Julie S Schwartzman-Morris; Michael Krathen; George Reed; Hong Chang; Katherine C Saunders; Mark C Fisher; Jeffrey D Greenberg; Chaim Putterman; Philip J Mease; Alice B Gottlieb; Joel M Kremer; Anna Broder
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

3.  Inflammatory Myopathy.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-07       Impact factor: 3.972
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.